as 02-11-2025 9:30am EST
AbbVie is a pharmaceutical firm with a strong exposure to immunology (with Humira, Skyrizi, and Rinvoq) and oncology (with Imbruvica and Venclexta). The company was spun off from Abbott in early 2013. The 2020 acquisition of Allergan added several new products and drugs in aesthetics (including Botox).
Founded: | 2012 | Country: | United States |
Employees: | N/A | City: | NORTH CHICAGO |
Market Cap: | 338.4B | IPO Year: | N/A |
Target Price: | $209.60 | AVG Volume (30 days): | 6.6M |
Analyst Decision: | Strong Buy | Number of Analysts: | 21 |
Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
EPS: | 2.39 | EPS Growth: | -12.13 |
52 Week Low/High: | $153.58 - $207.32 | Next Earning Date: | 01-31-2025 |
Revenue: | $56,334,000,000 | Revenue Growth: | 3.71% |
Revenue Growth (this year): | 7.21% | Revenue Growth (next year): | 7.50% |
Name | Ticker | Relationship | Date | Transaction | AVG Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Buckbee Kevin K | ABBV | SVP, CONTROLLER | Dec 16 '24 | Sell | $172.24 | 1,800 | $310,032.00 | 6,983 |
ABBV Breaking Stock News: Dive into ABBV Ticker-Specific Updates for Smart Investing
StockStory
2 hours ago
GuruFocus.com
4 hours ago
StockStory
a day ago
BioPharma Dive
a day ago
Zacks
a day ago
Pharmaceutical Technology
a day ago
Motley Fool
2 days ago
StockStory
2 days ago
The information presented on this page, "ABBV AbbVie Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.